Exicure, Inc. Recruits Head of Corporate Development and Bioinformatics
August 08 2024 - 4:27PM
Business Wire
Anna Chukaeva has been appointed as Senior Vice President, Head
of Corporate Development and Bioinformatics of Exicure, Inc. (“the
Company”) (Nasdaq: XCUR). Anna will spearhead investments,
acquisitions, and strategic partnerships. She will also push into
leveraging data and AI for drug discovery and diagnostics.
Anna was the co-founder, President and COO of Carta Healthcare,
an AI healthcare data company which has raised over $50 million in
venture financing. While leading operations for 5 years, she
directly led the 40-person, multi-national engineering and product
team to design and develop enterprise-scale data software products
adopted by hospital systems nationwide.
She received a bachelor’s degree in mathematics, a master’s in
economics, and an MBA from Stanford.
About Exicure, Inc.
Exicure, Inc. has historically been an early-stage biotechnology
company focused on developing nucleic acid therapies targeting
ribonucleic acid against validated targets. Following its recent
restructuring and suspension of clinical and development
activities, the Company is exploring strategic alternatives to
maximize stockholder value, both with respect to its historical
biotechnology assets and more broadly. For further information, see
www.exicuretx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240808332746/en/
Josh Miller 847-673-1700 media@exicuretx.com
Exicure (NASDAQ:XCUR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Exicure (NASDAQ:XCUR)
Historical Stock Chart
From Sep 2023 to Sep 2024